Key result
Anxiety and mood disorders causally increase CVD risk via shared genetic and environmental mechanisms.
Why the study?
The co-occurrence of mental and somatic disorders is an increasing concern in healthcare, prominently illustrated by the comorbidity of anxiety and mood disorders with cardiovascular disease.
Does treatment of anxiety and mood disorders improve cardiovascular disease outcomes in patients with comorbid conditions?
Does treatment of anxiety and mood disorders improve cardiovascular disease outcomes in patients with comorbid conditions?
The comorbidity of anxiety and mood disorders with cardiovascular disease is mediated by shared genetic and environmental risk factors, with evidence supporting a causal effect of AMD on CVD risk.
Answers are grounded in this paper and cite their sources.
Supports AMD treatment in comorbid CVD; confirms genetic causality and reinforces RCT meta-analyses.
An increasing concern in healthcare is the co-occurrence of mental and somatic disorders in patients, illustrated most prominently by the comorbidity of anxiety and mood disorders (AMD) with cardiovascular disease (CVD). Here we show that this comorbidity is largely mediated by genetic and environmental effects on risk mechanisms from the biological, behavioral, psychological and social domains shared by AMD and CVD. Genetically informative designs support the causal effects of AMD on the risk of CVD but show no evidence of reverse causality. This aligns with meta-analyses of randomized controlled trials that support positive effects of AMD treatment on CVD but find no consistent effects in the opposite direction. We suggest that patients with both CVD and AMD would benefit from a collaborative care approach. Interventions should focus on modifiable shared risk factors for both conditions, with lifestyle improvement and stress management appearing most promising.
No takes yet. Share an insight, caveat, or question.
Geus et al. (2026) conducted a review in Anxiety and mood disorders (AMD) and cardiovascular disease (CVD). Anxiety and mood disorders (AMD) was evaluated on Risk of cardiovascular disease. Anxiety and mood disorders have a causal effect on the risk of cardiovascular disease, largely mediated by shared genetic and environmental risk mechanisms, with no evidence of reverse causality.
Synapse has enriched 10 related papers. Consider them for comparative context: